Mergermarket Private Equity and M&A Forum Germany 2024

Our flagship event for key players in the German private equity and M&A market

Marriott Hotel, Frankfurt, 60486

23 Apr

Opening panel: Private equity dynamics in DACH

Germany, a key player in the European M&A landscape, boasts a robust economy and a significant presence in cross-border transactions, particularly in the technology, healthcare, automotive, and industrials sectors. DACH private equity professionals are gearing up for a surge in activity, fuelled by a backlog of deals from 2023 and the anticipation of fresh opportunities in 2024. Join this exclusive session where industry leaders will dissect the intricacies of the DACH M&A landscape, focusing on the unique considerations and strategies employed by both private equity sponsors and corporates in cross-border transactions. 

  • How are private equity firms approaching deal origination? What is the role of strategic partnerships and networks in deal sourcing? 
  • In the context of cross-border M&A, how do private equity sponsors structure deals to strike the right balance between risk and reward for optimal outcomes? 
  • What are the distinctive approaches utilised by private equity professionals in navigating the German M&A arena, from deal inception to post-merger integration? 
  • What exit opportunities exist for in cross-border transactions? How do private equity professionals position themselves for successful exits? 
  • Will 2024 see more mega-deals in Germany compared to 2023? What factors might contribute to a potential increase in large-scale transactions?
image image image image image image
  • Speakers keyboard_arrow_down
    Andrejs Klisans Country Manager 36Brains Bio
    Holger Kleingarn Managing Director H.I.G Capital Bio
    Roumyana Schnettler Partner CAPITON AG Bio
    Dominik Schwarz Partner VERDANE Bio
    Franz Reiffenstuel Partner ADELIS EQUITY PARTNERS
    Gustav Sandstrom Senior News Editor EMEA, Public Markets MERGERMARKET

Loading feed